These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

With biotech firms caught in the crosshairs of Trump’s tariffs, the levy could prove to be a boon for domestic producers but a bane for exporters.

Tenthoff, senior research analyst at Piper Sandler. “While macro headlines/tweets continue to dictate stock performance, and ...

Recursion Pharmaceuticals' stock jumped after the FDA announced ... drugmakers give it more stability than many clinical-stage biotech companies have. The company is also backed by Nvidia.

The biotech firm, known for its ambitious de-extinction ... His post included two photos- a Time Magazine cover showing a wolf-like animal with the title “Extinct” crossed out at the top ...

RCUS), a biotechnology company focused on developing innovative cancer therapies, has been attracting significant attention from investors and analysts alike. With a market capitalization of $782 ...

Markle shared some childhood Girl Scout photos to celebrate. [People] ⚾ On the field, after bringing the Dodgers back down to Earth, the Phillies take on the Braves at 7:15 p.m. ET on the MLB app.

Amgen, known for its focus on human therapeutics, has maintained a strong presence in the biotech industry ... as a potential catalyst for Amgen's stock. Analysts expect MariTide to demonstrate ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

American biotechnology company Colossal Biosciences on Monday announced that it brought back a formerly extinct species called dire wolf through what it described as the “world’s first de ...